Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH) News

Dutasteride for Low-Risk Prostate Cancer: Debate Heats Up The benign prostatic hyperplasia drug has the makings of a treatment for men on active surveillance, say the authors of a new study. No way, say critics.
Medscape Medical News, January 24, 2012
Bipolar Energy TURP Matches Standard TURP for Long Term Results Transurethral resection of the prostate with the PlasmaKinetic bipolar laser system offers long-term results similar to those from conventional monopolar TURP.
Reuters Health Information, January 3, 2012

Tell Patients: No Urinary Relief From Saw Palmetto Saw palmetto is popular among men with enlarged prostates seeking improvement in lower urinary tract symptoms, but a new study found no clinical benefit from the supplement. Dr. Gerald Chodak discusses the patient care issues involved.
Medscape Urology, October 12, 2011
Botulinum Toxin for Treatment of LUTS Secondary to BPH Investigators conducted a randomized phase 2 clinical trial to explore the effects of onabotulinum toxin A on lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Medscape Urology, October 11, 2011

Recent Advances in Surgery for Benign Prostatic Hyperplasia
Therapeutic Advances in Urology, January 11, 2012
Bipolar Vaporization of the Prostate
Therapeutic Advances in Urology, January 4, 2012
Treating Lower Urinary Tract Symptoms With Saw Palmetto
Journal Watch, November 13, 2011
Serenoa Repens Extract for Benign Prostatic Hyperplasia
Therapeutic Advances in Urology, October 17, 2011
The Impact of Current BPH Treatment on Sexual Function
International Journal of Clinical Practice, October 13, 2011